2020 Accomplishments Report

NCI Again Rates OSUCCC – James as ‘Exceptional’ and Renews CCC Status

For the third consecutive time, the National Cancer Institute (NCI) in 2020 rated Ohio State’s cancer program as “exceptional” — the highest rating provided — following a review of the OSUCCC – James’ application for re-designation as a Comprehensive Cancer Center and a virtual site visit by a team of NCI surveyors.

NCI Again Rates OSUCCC – James as ‘Exceptional’ and Renews CCC Status

The OSUCCC – James thus retains a designation it has maintained since 1976 through a competitive peer-review process that includes both written and on-site evaluation of the research program and infrastructure. The re-designation will extend for five years and will provide the cancer program with an estimated $33 million Cancer Center Support Grant (CCSG) from the NCI. The CCSG supports research programs, community outreach and engagement, education and training, clinical trial infrastructure, center senior leadership and administration, shared resource facilities and program development.

NCI designation as a Comprehensive Cancer Center is the most prestigious recognition a cancer program can receive, providing an external and expert validation of the breadth and depth of an institution’s cancer research efforts and of how the institution translates those discoveries into excellent patient care.

“This exceptional ranking from the NCI is a tribute to the dedication of our team of nearly 300 scientists and clinician-investigators working in laboratory, translational, clinical and population sciences to advance cancer discoveries that will improve care at the bedside,” says OSUCCC director Raphael E. Pollock, MD, PhD, FACS. “We are honored to continue this important work that will lead us toward a cancer-free world.”

OSUCCC Cancer Center Support Grant by the Numbers, 2015-2020

CCC Facts Graphics